A sample of ["H] tobrarnycin (5,000 Ci/Mole) has been synthetized and incubated with the bacterial ribosome and its subunits. The results obtained show that this antibiotic has tw.) types of binding sites. The primary one is probably responsible for the inhibition of protein synthesis whereas the secondary one is probably related to the misreading and reading tiirough of the messenger RNA.
It has been demonstrated recently',-' that, at a low concentration, gentamicin, a powerful aminoglycoside antibiotic, is able to inhibit protein synthesis to a large extent whereas at higher concentrations this drug catalyzes misreading and reading-through of the messenger RNA. This biphasic process has probably some correlation to the presence of two types of binding sites on the ribosome: one site responsible for inhibition of the chain elongation; the other, for reversing inhibition, induction of misreading and reading-through of mRNA.
Binding experiments performed by MIsuMI et al." with kanamycin, neomycin and gentamicin on washed ribosomes and ribosomal subunits also showed that these drugs can bind to the ribosome, 50 S as well as to the 30 S subunit.
The present paper deals with the binding of tobramycin job), an antibiotic related in structure to kanamycin and gentamicin, to the bacterial ribosome and its subunits.
Evidence is presented which shows that, as predicted, this drug has two types of selective binding sites on the ribosome itself as well as on the 50 S subunit, while it has only one type of binding site on the 30 5 subunit.
Materials and Methods

Chen icals
Tritiated borohydride was from C.E.A. and had a specific radioactivity of 25,000 Ci/mole. Tobramycin was obtained from Eli Lilly; [3H] tobramycin ([3H] Tob) was synthetized by a method described previously for the synthesis of derivatives of 3'-deoxyparomomycirr": the amino-functions of tobramycin were protected by ethoxycarbonylation and the secondary hydroxyl groups by acetylation. The derivative thus synthetized was oxidized by the dimethyIsuIfoxide-pyridine-trifluoroacetic acid complex to tha corresponding 6" aldehyde which was then purified by column chromatography on silicic acid for an overall yield of 45;x. Nine mg of this aldehyde were dissolved in I ml of methanol, added to 4.10-0 mole of BT4Na (25,000 Ci/mole) in I ml of 0.01 M NaOH and stirred for 1 hour at room temperature.
Methanol was then removed under vacuum and the residue treated with I ml of a water solution of barium hydroxide (0.5 M) at 100"C for IS hours.
Dry ice (1 g) was added to the medium; the precipitate was eliminated by filtration.
The filtrate thus obtained was submitted to lyophilization. Biological material Tight and run off ribosomes were prepared by zonal centrifugation as described previously' from an Sso fraction of synchronized E. co/i MRE 600. The ribosomal fractions thus obtained were concentrated with polyethyleneglycol. The ribosomal subunits (30 S and 50 S) were, again, prepared as described previously-" by zonal centrifugation in the presence of a 0.4 M sodium chloride solution. The ribosomes and their subunits remained stable for months at -20'C in buffer A (10 mm tris-HCI, 10 mM Mg(OAc)_, 100 mm NH4CI, 6 mm /3-mercaptoethanol, pH 7.8).
One A", unit corresponds to 24 p mole/ml of 70 S, 69 p mole/ml of 30 S and 35 p mole/ml of 50 S.
Equilibrium dialysis
To determine the properties of the reversible complex ['H] Tob-biological particule, a Dianorm apparatus, whose rotating cells had a total volume of 50011, was used. Two compartments were formed by a semipermeable membrane (Visking) which had been soaked, beforehand at room temperature in the following buffer: 10 mM Tris-HCI pH 7.6, 100 mm NH<CI, 10 mm Mg(OAc),. 200/11 of the biological preparation (R,) were introduced in one compartment of the cell and 200 /d of increasing concentrations (from 5.10-'M) of tobramycin in the other. In addition, a similar quantity (2.10-3 mole: 8. 10' dmp) of the synthetized [3H] Tob was introduced into the cell with the tobramycin solution.
When equilibrium was reached (20 hours at 4Q, 100 /d of solution was pipetted from each compartment. The concentrations of bound antibiotic (C") and free antibiotic (C,.) as given by equations (1) and (2): With the 30 S subunit, only one steady decrease in bound radioactivity was observed before to a plateau representing non-specific binding was reached.
The SCATCHARD plot of a/CF• against /t is linear for identical binding sites, with a slope equal to -11K, (K,,: dissociation constant of the complex studied) and the abscissa intercept equal to n (number of binding sites per particule).
When results of Table 1 .
More accurate values for these constants could be obtained, especially for the primary binding sites located on the 70 S and the 50 S particules, by substracting non-specific binding, represented in relatively !ow and the substraction of non-specific binding leads to an underestimation of the molecules bound to the biological particule.
The same type of secondary binding site is also present in the ribosomal subunits.
Our results correlate exactly with experiments reported by DAVIS and BccK' ~" who demonstrated that a tight binding site was probably responsible for the inhibition of protein synthesis which occurs when concentrations lower than I pg/ml of gentamicin are reached in the medium. At higher concentrations of the drug, primary as well as secondary binding sites are occupied. There is a subsequent small increase i i protein synthesis which coincides with the appearance of misreading and reading-through of mRNA. Our results also correlate with those of MlsuMi et al." who demonstrated a selective binding of kanamycin A, neomycin and gentamicin to the bacterial ribosome as well as to its subunits. Based on these results, it is possible to propose the following model: at low concentrations, one molecule of tobramycin is bound to the high affinity binding site leading to inhibition of protein synthesis. A. higher concentrations, several molecules of Tob are bound to the low affinity binding sites provoking the appearance of misreading. Additional experiments are now under way which will better our knowledge of these binding sites and their function in protein synthesis.
